. "Appendix D: Biographical Sketches of Committee Members." BioWatch and Public Health Surveillance: Evaluating Systems for the Early Detection of Biological Threats: Abbreviated Version. Washington, DC: The National Academies Press, 2011.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Biowatch and Public Health Surveillance: Evaluating Systems for the Early Detection of Biological Threats - Abbreviated Version
Joseph M. DeSimone (Vice Chair) is the Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and the William R. Kenan, Jr. Professor of Chemical Engineering at North Carolina State University. He also serves as director of the National Science Foundation Science and Technology Center for Environmentally Responsible Solvents and Processes and is co-principal investigator for the Carolina Center for Cancer Nanotechnology Excellence. He is also the director of the Institute for Advanced Materials, Nanoscience, and Technology at UNC-CH. Among Dr. DeSimone’s notable inventions is an environmentally friendly manufacturing process that relies on supercritical carbon dioxide for the creation of fluoropolymers, such as Teflon®. More recently, he worked with a team to design a polymer-based, fully bioabsorbable, drug-eluting stent, which helps keep a blocked blood vessel open after a balloon-angioplasty and is absorbed by the body within 18 months. Dr. DeSimone’s current interests are focused on applied fabrication technologies from the microelectronics industry to make nanocarriers for use in medicine. Dr. DeSimone holds more than 115 issued patents with more than 70 new patent applications pending, and he has published more than 240 peer-reviewed scientific articles. In 2005, Dr. DeSimone was elected into both the National Academy of Engineering and the American Academy of Arts and Sciences. He has received numerous awards and recognition, including the Lemelson-MIT Prize (2008), the Presidential Green Chemistry Challenge Award (1997), the Engineering Excellence Award by DuPont (2002), and the American Chemical Society Award for Creative Invention (2005). He is the cofounder of Liquidia Technologies, Inc., and a cofounder of BioStent, which was sold to Guidant (now Abbott Vascular). At the National Academies, he has served on the Division on Earth and Life Studies’ Board on Chemical Sciences and Technology. Dr. DeSimone earned his B.S. in chemistry from Ursinus College and his Ph.D. in chemistry from the Virginia Polytechnic Institute and State University.
Michael S. Ascher is the Senior Medical Advisor to the California Emergency Management Agency (CALEMA) and a visiting researcher in the Department of Medicine and Epidemiology, University of California (Davis) School of Veterinary Medicine. Previously, he has been the lead for biological defense activities in the California Department of Health Services and principal investigator of the CDC grant to the state for preparedness and response. Other past positions include chief of the Viral and Rickettsial Laboratory, Division of Communicable Disease Control, at the California Department of Health Services. He also served in the U.S. Army as chief of medicine and in the Bacteriology Division at the U.S. Army Medical Research Institute of Infectious Diseases. In the area of biological defense, he has served on the Armed Forces Epidemiological Board and an interagency advisory panel on Biological Warfare Preparedness for the 21st Century. He has consulted for the Department of Defense, the Centers for Disease Control and Prevention, MITRE Corporation, the National Domestic